Actavis Buys U.S. Pharmaceutical Company Allergan Skip to content

Actavis Buys U.S. Pharmaceutical Company Allergan

By Iceland Review

Pharmaceutical company Actavis, which is headquartered in Iceland, has acquired U.S. pharmaceutical company Allergan for USD 70.5 billion (ISK 10,000 billion, EUR 66.4 billion). The acquisition was announced in November but formally went through yesterday.

Actavis will consequently adopt the name Allergan, provided the shareholders approve. The merged companies will become one of the ten largest pharmaceutical companies in the world, both in the field of reference medicine and generic drugs, Vísir reports.

With operations in more than 100 countries, Actavis-Allergan will have an estimated revenue of USD 23 billion for 2015.

Following the merger, a rationalization worth ISK 1.8 billion will take place at the two companies in the next 12 months.

Sign up for our weekly newsletter

Get news from Iceland, photos, and in-depth stories delivered to your inbox every week!

* indicates required

Subscribe to Iceland Review

In-depth stories and high-quality photography showcasing life in Iceland!